Di Procolo, Paolo, Medical & Market Access Department, Roche Diagnostics SpA, Monza, Italy

• Vol 21, No 1 (2020) - Original research
  Clinical Impact of two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
  Abstract  HTML  PDF